Also trades as: PTIXW (NASDAQ) · $vol 0M
PTIX OTC
Protagenic Therapeutics, Inc.
1W: +0.0%
1M: -26.3%
3M: +248.8%
YTD: +4.6%
1Y: -77.1%
3Y: -96.9%
5Y: -99.3%
$0.77
-0.01 (-0.78%)
Weekly Expected Move ±17.6%
$1
$1
$1
$1
$1
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Supply Chain
Income Trends
Revenue
$0
+0.0% ▲
Gross Profit
-$38K
+25.0% ▲
Operating Income
-$6M
-2.3% ▼
Net Income
-$5M
+6.7% ▲
EPS (Diluted)
$-3.45
-205.3% ▼
EBITDA
-$8M
-46.6% ▼
Profit Margins
Year-over-Year Growth
View Full Income Statement
| Line Item | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 | $0 |
| YoY Growth | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% |
| Cost of Revenue | $0 | $30 | $28K | $50K | $38K |
| Gross Profit | $0 | -$30 | -$28K | -$50K | -$38K |
| Gross Margin | — | — | — | — | — |
| R&D Expenses | $1M | $2M | $3M | $4M | $2M |
| SG&A Expenses | $3M | $2M | $1M | $2M | $2M |
| Operating Expenses | $4M | $4M | $4M | $6M | $6M |
| Operating Income | -$4M | -$4M | -$5M | -$6M | -$6M |
| Operating Margin | — | — | — | — | — |
| Interest Expense | $497K | $137K | $108K | $0 | $297K |
| Income Before Tax | -$5M | -$4M | -$5M | -$6M | -$5M |
| Tax Expense | $0 | $0 | $0 | $0 | $0 |
| Net Income | -$5M | -$4M | -$5M | -$6M | -$5M |
| Net Margin | — | — | — | — | — |
| EPS (Diluted) | $-1.24 | $-0.82 | $-1.15 | $-1.13 | $-3.45 |
| EBITDA | -$4M | -$3M | -$4M | -$5M | -$8M |
| Shares Outstanding | 4M | 4M | 4M | 5M | 2M |